Synergistic effects were further demonstrated using the synergy finder website in MOLM-14 cells and in seven primary AML samples treated with increasing concentrations of both VPS34-IN1 and l-asparaginase (Fig. 4E, F and Supplemental Fig. 6). This evidence concerns the gene PIK3C3 and acute myeloid leukemia.